Hypersensitivity pneumonitis : a broader perspective

Area of Science:

• Pulmonary Medicine
• Immunology
• Environmental Health

Background:

• Hypersensitivity pneumonitis (HP) encompasses lung disorders triggered by inhaling diverse organic particles in susceptible individuals.
• While primarily affecting non-smokers, smoking can exacerbate HP into chronic forms, with prevalence varying widely across age groups.
• HP presents acutely with flu-like symptoms, or subacutely/chronically with progressive dyspnea and cough due to recurrent antigen exposure.

Purpose of the Study:

• To outline the clinical spectrum, diagnostic approaches, and management strategies for hypersensitivity pneumonitis.
• To emphasize the importance of antigen identification and avoidance in HP management.
• To detail the diagnostic criteria involving clinical, imaging, laboratory, and pathological findings.

Main Methods:

• Review of clinical presentations (acute, subacute, chronic) and associated symptoms.
• Analysis of diagnostic tools including laboratory tests, antibody detection, imaging (radiography, HRCT), pulmonary function tests, bronchoalveolar lavage, and lung biopsy.
• Evaluation of treatment modalities focusing on antigen avoidance and corticosteroid therapy.

Main Results:

• HP diagnosis relies on a combination of exposure history, clinical symptoms, and specific findings from imaging, lavage, and biopsy.
• Characteristic findings include ground-glass opacities, nodules, restrictive ventilatory defects, lymphocytic alveolitis, and granulomas.
• Effective treatment involves antigen avoidance, with corticosteroids recommended for subacute and chronic HP.

Conclusions:

• Hypersensitivity pneumonitis presents diverse clinical forms and requires a multi-faceted diagnostic approach.
• Early identification of causative antigens and prompt treatment are crucial to prevent irreversible lung damage.
• Management strategies focus on environmental control and pharmacotherapy, primarily corticosteroids.